We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.71%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.11B
AUM Growth
+$140M
(+4.7%)
Cap. Flow
-$15.5M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
31.89%
Holding
3,618
New
197
Increased
1,211
Reduced
1,199
Closed
259
Avg Time Held Equity + Options
3.7
years
Top 10 Avg Time Held Equity + Options
2.1
years
Top 20 Avg Time Held Equity + Options
2.5
years
Avg Time Held Equity only
3.7
years
Top 10 Avg Time Held Equity only
2.1
years
Top 20 Avg Time Held Equity only
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$72.4M |
| 2 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
+$18.9M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$9.7M |
| 4 |
iShares MSCI EAFE Growth ETF
EFG
|
+$3.85M |
| 5 |
Confluent
CFLT
|
+$3.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$39.5M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$19.1M |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$18.1M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$16.4M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$7.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.46% |
| 2 | Technology | 15.44% |
| 3 | Healthcare | 8.51% |
| 4 | Financials | 6.64% |
| 5 | Consumer Discretionary | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3026
Avita Medical
RCEL
$415M
| $680 | ﹤0.01% |
40
| – | – |
2021 Q1
9 quarters
|
|
3027
Eagle Bancorp
EGBN
$854M
| $677 | ﹤0.01% |
+32
| New | +$753 |
2023 Q2
0 quarters
|
|
3028
Kosmos Energy
KOS
$1.6B
| $677 | ﹤0.01% |
113
+45
| +66% | +$293 |
2021 Q4
6 quarters
|
|
3029
Energy Vault
NRGV
$556M
| $674 | ﹤0.01% |
247
| – | – |
2023 Q1
1 quarter
|
|
3030
StepStone Group
STEP
$3.51B
| $670 | ﹤0.01% |
27
-28
| -51% | -$643 |
2022 Q1
5 quarters
|
|
3031
Evolent Health
EVH
$551M
| $667 | ﹤0.01% |
22
-17
| -44% | -$550 |
2021 Q1
9 quarters
|
|
3032
Levi Strauss
LEVI
$7.92B
| $664 | ﹤0.01% |
+46
| New | +$664 |
2023 Q2
0 quarters
|
|
3033
NovoCure
NVCR
$1.68B
| $664 | ﹤0.01% |
16
-148
| -90% | -$9.19K |
2020 Q4
10 quarters
|
|
3034
Ryman Hospitality Properties
RHP
$8.65B
| $659 | ﹤0.01% |
7
-25
| -78% | -$2.3K |
2021 Q4
6 quarters
|
|
|
ESTE
3035
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $657 | ﹤0.01% |
46
| – | – |
2021 Q2
8 quarters
|
|
3036
SkinHealth Systems
SKIN
$82M
| $653 | ﹤0.01% |
+4
| New | +$831 |
2023 Q2
0 quarters
|
|
3037
Trustmark
TRMK
$2.61B
| $653 | ﹤0.01% |
30
-1,419
| -98% | -$32K |
2016 Q4
26 quarters
|
|
3038
Northern Oil and Gas
NOG
$2.74B
| $652 | ﹤0.01% |
19
| – | – |
2022 Q2
4 quarters
|
|
3039
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $652 | ﹤0.01% |
60
| – | – |
2023 Q1
1 quarter
|
|
3040
Agios Pharmaceuticals
AGIO
$1.93B
| $651 | ﹤0.01% |
+23
| New | +$572 |
2023 Q2
0 quarters
|
|
3041
Definitive Healthcare
DH
$106M
| $649 | ﹤0.01% |
59
+11
| +23% | +$113 |
2022 Q4
2 quarters
|
|
3042
World Kinect Corp
WKC
$1.88B
| $646 | ﹤0.01% |
31
-31
| -50% | -$738 |
2019 Q3
15 quarters
|
|
3043
Design Therapeutics
DSGN
$656M
| $643 | ﹤0.01% |
102
+52
| +104% | +$318 |
2023 Q1
1 quarter
|
|
3044
DELISTED
Olo Inc
OLO
| $640 | ﹤0.01% |
99
-38
| -28% | -$273 |
2022 Q3
3 quarters
|
|
3045
Shoals Technologies Group
SHLS
$1.31B
| $639 | ﹤0.01% |
25
| – | – |
2022 Q2
4 quarters
|
|
3046
DELISTED
RE/MAX Holdings
RMAX
| $636 | ﹤0.01% |
33
| – | – |
2020 Q1
13 quarters
|
|
3047
Onterris Inc
ONT
$494M
| $632 | ﹤0.01% |
+15
| New | +$539 |
2023 Q2
0 quarters
|
|
3048
LSB Industries
LXU
$753M
| $630 | ﹤0.01% |
+64
| New | +$612 |
2023 Q2
0 quarters
|
|
3049
Kemper
KMPR
$1.67B
| $627 | ﹤0.01% |
13
+1
| +8% | +$48 |
2019 Q2
16 quarters
|
|
3050
Pan American Silver
PAAS
$18.1B
| $627 | ﹤0.01% |
43
-44
| -51% | -$727 |
2020 Q2
12 quarters
|
|
Similar funds
Parallel Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Parallel Advisors held 3,618 positions worth $3.11B, up 4.7% from $2.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Parallel Advisors's Q2 2023 filing shows 197 new, 1,211 increased, 1,199 reduced and 259 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $39.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 50% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2023 buy was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K.
- Parallel Advisors added most to iShares MSCI USA Quality Factor ETF in Q2 2023, an estimated $72.4M increase.
- Parallel Advisors's biggest Q2 2023 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $39.5M.
- Parallel Advisors fully exited Cvent Holding Corp. Common Stock in Q2 2023, selling an estimated $1.62M.
- Parallel Advisors's ten largest holdings make up 32% of its $3.11B portfolio in Q2 2023.
- Parallel Advisors opened 197 new positions and closed 259 in Q2 2023.
- Parallel Advisors's portfolio value rose 4.7% quarter-over-quarter to $3.11B.
Based on Parallel Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.